Summary The NHS is expanding access to artificial pancreas technology for individuals with Type 1 diabetes, thanks to new cost-effective deals. This groundbreaking technology automatically monitors and adjusts insulin levels, promising improved health and quality […]
Summary New research suggests that indulging in dark chocolate might offer more than just a delicious treat. Studies indicate a link between regular dark chocolate consumption and a reduced risk of developing type 2 diabetes, […]
Summary This article explores the emerging concept of “activity snacking” for managing type 1 diabetes. Research suggests that short bursts of activity throughout the day can significantly improve blood sugar control and overall health. This […]
Summary This article explores the groundbreaking advancements in diabetes management fueled by significant investments in research. From innovative drug therapies and technological devices to stem cell research and immunotherapies, the landscape of diabetes care is […]
Summary Professor Dame Stephanie Amiel’s Damehood highlights her contributions to diabetes care, from DAFNE to hypoglycemia research. The article also explores advancements in diabetes management, including CGM, automated insulin delivery, and new drug classes. These […]
Summary This article delves into the groundbreaking development of the first insulin pump, a pivotal moment in diabetes management. From its bulky beginnings to its modern, sophisticated iterations, the insulin pump has transformed the lives […]
Summary A novel anti-clotting drug, abelacimab, has shown remarkable success in reducing bleeding events in patients with atrial fibrillation, a common heart condition that increases stroke risk. This breakthrough offers a safer alternative to current […]
Summary This article explores the latest breakthroughs in type 1 diabetes research, including innovative immunotherapies, smart insulin patches, and the potential of stem cell therapy and islet transplantation. These advancements offer hope for a future […]
Summary Medicare has selected 15 drugs, including the popular diabetes and weight-loss drug semaglutide, for its second round of price negotiations under the Inflation Reduction Act. The negotiations aim to lower prescription drug costs for […]
Summary The Diabetes Technology Society (DTS) has introduced a new error grid to enhance the accuracy assessment of continuous glucose monitors (CGMs). This grid refines risk zones, incorporates CGM trend analysis, and offers a more […]
© 2025 Newsguru LTD. All rights reserved.